Lv7
5000 积分 2021-09-26 加入
Reprogramming the immune microenvironment in triple-negative breast cancer with mRNA therapeutics
1个月前
已完结
NN-01-195, a Novel Conjugate of HSP90 and AURKA Inhibitors, Effectively Targets Solid Tumors
2个月前
已完结
First-in-Human Dose-Escalation Study of Cyclin-Dependent Kinase 9 Inhibitor VIP152 in Patients with Advanced Malignancies Shows Early Signs of Clinical Efficacy
2个月前
已完结
Artificial intelligence in drug discovery — what it is, where we stand and the path forward
2个月前
已完结
CDK9 degrader induces BRCAness and sensitizes castration-resistant prostate cancer to PARP inhibitor
2个月前
已完结
Property-based optimisation of PROTACs
3个月前
已完结
Proteolysis-targeting chimeras with reduced off-targets
4个月前
已完结
Proteolysis‐targeting chimeras in drug development: A safety perspective
4个月前
已完结
Safety considerations for cereblon-recruiting targeted protein degraders
4个月前
已完结
An epigenetic bifunctional that toggles between transactivation and repression
5个月前
已关闭
皖公网安备34019202002308
